N'-(4-(1H-pyrrol-1-yl)benzoyl)-4-bromobenzohydrazide | 1009955-14-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: N'-(4-(1H-pyrrol-1-yl)benzoyl)-4-bromobenzohydrazide
• 英文别名: N'-(4-bromobenzoyl)-4-pyrrol-1-yl-benzohydrazide；N'-(4-bromobenzoyl)-4-pyrrol-1-ylbenzohydrazide
• CAS: 1009955-14-9
• 化学式: C₁₈H₁₄BrN₃O₂
• 分子量: 384.232
• InChiKey: ZSFCTLNLWSYABA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N'-(4-(1H-pyrrol-1-yl)benzoyl)-4-bromobenzohydrazide 在 四磷十氧化物 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 以76%的产率得到2-(4-bromophenyl)-5-[4-(1H-pyrrol-1-yl)phenyl]-1,3,4-oxadiazole
  参考文献：
  名称：

  合成新的4-（2,5-二甲基吡咯-1-基）/ 4-吡咯-1-基苯甲酰肼类似物和一些衍生的恶二唑，三唑和吡咯环系统：一类新型的潜在抗菌剂，抗真菌剂和抗结核剂

  摘要：

  摘要一系列4-（2,5-二甲基吡咯-1-基）/ 4-吡咯-1-基苯甲酸酰肼类似物，一些衍生的1,3,4-恶二唑，5-取代的-4-氨基-1,2合成了高产率的1，4-三唑啉-3-硫酮和2，5-二甲基吡咯，并通过IR，1 H NMR，13 C NMR，质谱和元素分析确定了这些化合物的结构。通过肉汤稀释法评价这些化合物对结核分枝杆菌H 37 Rv菌株的初步体外抗菌，抗真菌和抗结核活性。这些化合物中的十二种显示出良好的抗菌活性，最小抑菌浓度（MIC）值为1-4μgmL -1。几种化合物4，8D，9，12C - d和12F - ħ体外抗结核活性显示出良好的与MIC值1-2微克毫升-1。此外，还使用MTT测定法评估了一些标题化合物对哺乳动物Vero细胞系和A 549（肺腺癌）细胞系的细胞毒活性（IC 50）。结果表明，这些化合物在非细胞毒性浓度下具有抗结核活性。 图形概要描述了一系列新型吡咯衍生物的合成，光谱研究以及抗菌，抗真菌和抗结核活性

  DOI：

  10.1007/s00044-012-0112-0
• 作为产物：
  描述：

  苯佐卡因 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 一水合肼 、 溶剂黄146 、 N,N-二异丙基乙胺 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.75h， 生成 N'-(4-(1H-pyrrol-1-yl)benzoyl)-4-bromobenzohydrazide
  参考文献：
  名称：

  Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors

  摘要：

  In efforts to develop lead anti-TB compounds, a novel series of 19 pyrrolyl benzohydrazides were synthesized and screened to target enoyl-ACP reductase enzyme, which is one of the important enzymes involved in type II fatty acid biosynthetic pathway of M. tuberculosis. Pharmacophores were constructed using GALAHAD to generate alignment of data sets and calculated by Pareto ranking. The pharmacophore features were then filtered by Surfiex-dock study using enoyl ACP reductase from M. tuberculosis. Compounds 5b and 5d showed H-bonding interactions with Tyr158, Thr196 and co-factor NAD(+) that fitted well within the binding pocket of InhA. All the synthesized compounds were screened for preliminary antibacterial activities against Gram-positive S. aureus and Gram-negative E. colt and M. tuberculosis H(37)Rv to evaluate their antitubercular activities. Some representative compounds were further tested for mammalian cell toxicity using human lung cancer cell-line (A549) that was found to be nontoxic. These compounds exhibited moderate inhibition activities against InhA. (C) 2016 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2016.11.032

文献信息

• Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors
  作者：Shrinivas D. Joshi、Sheshagiri R. Dixit、Venkatarao H. Kulkarni、Christian Lherbet、Mallikarjuna N. Nadagouda、Tejraj M. Aminabhavi

  DOI：10.1016/j.ejmech.2016.11.032

  日期：2017.1

  In efforts to develop lead anti-TB compounds, a novel series of 19 pyrrolyl benzohydrazides were synthesized and screened to target enoyl-ACP reductase enzyme, which is one of the important enzymes involved in type II fatty acid biosynthetic pathway of M. tuberculosis. Pharmacophores were constructed using GALAHAD to generate alignment of data sets and calculated by Pareto ranking. The pharmacophore features were then filtered by Surfiex-dock study using enoyl ACP reductase from M. tuberculosis. Compounds 5b and 5d showed H-bonding interactions with Tyr158, Thr196 and co-factor NAD(+) that fitted well within the binding pocket of InhA. All the synthesized compounds were screened for preliminary antibacterial activities against Gram-positive S. aureus and Gram-negative E. colt and M. tuberculosis H(37)Rv to evaluate their antitubercular activities. Some representative compounds were further tested for mammalian cell toxicity using human lung cancer cell-line (A549) that was found to be nontoxic. These compounds exhibited moderate inhibition activities against InhA. (C) 2016 Elsevier Masson SAS. All rights reserved.
• Synthesis of new 4-(2,5-dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial, antifungal and antitubercular agents
  作者：S. D. Joshi、Yogesh More、H. M. Vagdevi、V. P. Vaidya、G. S. Gadaginamath、V. H. Kulkarni

  DOI：10.1007/s00044-012-0112-0

  日期：2013.3

  values 1–4 μg mL−1. Several compounds 4, 8d, 9, 12c–d and 12f–h exhibited good in vitro antitubercular activity with MIC values 1–2 μg mL−1. Further, some title compounds were also assessed for their cytotoxic activity (IC50) against mammalian Vero cell lines and A549 (lung adenocarcinoma) cell lines using MTT assay method. The results reveal that these compounds exhibit antitubercular activity at non-cytotoxic

  摘要一系列4-（2,5-二甲基吡咯-1-基）/ 4-吡咯-1-基苯甲酸酰肼类似物，一些衍生的1,3,4-恶二唑，5-取代的-4-氨基-1,2合成了高产率的1，4-三唑啉-3-硫酮和2，5-二甲基吡咯，并通过IR，1 H NMR，13 C NMR，质谱和元素分析确定了这些化合物的结构。通过肉汤稀释法评价这些化合物对结核分枝杆菌H 37 Rv菌株的初步体外抗菌，抗真菌和抗结核活性。这些化合物中的十二种显示出良好的抗菌活性，最小抑菌浓度（MIC）值为1-4μgmL -1。几种化合物4，8D，9，12C - d和12F - ħ体外抗结核活性显示出良好的与MIC值1-2微克毫升-1。此外，还使用MTT测定法评估了一些标题化合物对哺乳动物Vero细胞系和A 549（肺腺癌）细胞系的细胞毒活性（IC 50）。结果表明，这些化合物在非细胞毒性浓度下具有抗结核活性。 图形概要描述了一系列新型吡咯衍生物的合成，光谱研究以及抗菌，抗真菌和抗结核活性